|
Status |
Public on Feb 19, 2019 |
Title |
Effect of BB608 on STAT3 DNA Binding in HNSCC Cell Line |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
Study to determine the genome wide effects on STAT3 binding in FaDu cells treated with BB608, a transcription factor inhibitor.
|
|
|
Overall design |
2 samples DMSO treated, ChIP using STAT1 or STAT3 antibody. 2 samples BB608 treated, ChIP using STAT1 or STAT3 antibody
|
|
|
Contributor(s) |
Ao Y, Harry R, Chen Z, Xiangao S, Chiang L |
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Feb 23, 2016 |
Last update date |
May 15, 2019 |
Contact name |
Harry Rogoff |
Organization name |
Boston Biomedical, Inc.
|
Street address |
640 Memorial Dr.
|
City |
Cambridge |
State/province |
MA |
ZIP/Postal code |
02139 |
Country |
USA |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (5)
|
|
Relations |
BioProject |
PRJNA312943 |
SRA |
SRP070705 |